The breast lesion localization methods market refers to the various techniques and devices used to locate and mark breast lesions prior to surgery. These methods include wire localization, radioisotope localization, magnetic seed localization, and other emerging techniques.
The breast lesion localization methods market will experience significant growth primarily due to an increasing incidence of breast cancer and the rising adoption of breast cancer screening programs. Additionally, advancements in imaging technologies and the development of more precise and efficient localization techniques are expected to further fuel market growth.
The market for breast lesion localization methods in 2021 was worth USD 966.56 million, and by 2030, it will reach USD 3038 million, growing at a 13.57% CAGR during the forecast period.
The wire localization technique is currently the most widely used method for breast lesion localization. However, the technique has some limitations, such as discomfort and the potential for wire migration, which can lead to inaccurate localization. To overcome these limitations, alternative techniques such as radioisotope and magnetic seed localization are gaining popularity.
Market Dynamics
Drivers
A major factor boosting market expansion is the enormous rise in breast cancer incidence from poor diets and changing lifestyles. In addition, the increasing need for surgical biopsy and lumpectomy treatments is increasing the need for breast lesion localization techniques to guarantee the correct removal of the target lesion. Additionally, the governing bodies of numerous nations are taking positive steps to raise knowledge of the advantages of early breast cancer diagnosis. The development of cutting-edge breast lesion localization devices by top companies and the rising number of government and private reimbursement schemes for breast cancer detection, biopsy, and other relevant medical procedures are accelerating the market expansion.
Restraints
However, the market’s expansion is hampered by factors, including stringent regulatory requirements and high expenses related to breast lesion localization techniques.
Opportunity
The breast lesion localization methods market is likely to benefit from the increasing government investments in developing and modernizing healthcare infrastructure. With greater investments, healthcare facilities can acquire more advanced technologies for breast lesion localization, boosting the demand for such devices in the market.
Market Segmentation
By Type
The wire localization segment was the largest market contributor, with a revenue share of nearly 32% in 2021. This is due to its cost-effectiveness, ease of use, and compatibility with radiology imaging devices. The government is also promoting breast cancer awareness programs, significantly boosting this market segment’s overall growth. Overall, these factors contribute to the growth of the Breast Lesion Localization device market during the forecast period.
By Usage
The breast Biopsy segment led the entire market with 62% of overall shares in 2021 and will expand at a 5% CAGR during the forecast period. This is likely due to the increasing awareness and emphasis on early diagnosis of breast lesions, leading to a higher demand for breast biopsy procedures. As a result, there is a significant market opportunity for the breast biopsy segment to grow and expand.
Regional Analysis
In 2021, North America led the entire market with a revenue share of nearly 35%. It is because established government programs for cancer screening are readily available, as are the reimbursement policies for the area. Most people with breast cancer live in the North American region, and the government is investing heavily in medical equipment and Breast Lesion Localization Devices. These elements are causing the Breast Lesion Localization Market in North American nations to expand.
Through the projection period, the European area will have considerable growth at a CAGR of 9%. Breast cancer patients have become more prevalent in European nations as a result of rising breast cancer prevalence and the use of cutting-edge localization techniques for the disease’s treatment. The market for the localization of breast lesions is expanding due to these considerations. Consequently, throughout the projection period, the European area is anticipated to expand considerably.
Key Players
- Becton, Dickinson, and Company
- Mermaid Medical A/S
- Argon Medical Devices
- IZI Medical Products
- Sirius Medical BV.
- Molli Surgical
- Tsunami Medical
- C.R. Bard,
- Laurane Medical
- Endomagnetics
- SOMATEX Medical Technologies GmbH
- Cianna Medical
- Cianna Medical
- CP Medical
- BPB Medica
- Cook Medical
- Leica Biosystems
- Health Beacons
- Elucent Medical
- Surgiceye GmbH.
- Intra-Medical Imaging
- Ranfac Corporation
- Hologic
- Sirius medical
The market for breast lesion localization methods in 2021 was worth USD 966.56 million, and by 2030 it will reach USD 3038 million, growing at a 13.57% CAGR during the forecast period. The rising prevalence of breast cancer is the main element driving the market’s expansion.
Related Reports:
Video Analytics Market Report – The global video analytics market will witness a robust CAGR of 23.1%, valued at $4.5 Billion in 2021, and expected to appreciate and reach $5.5 Billion in 2022 and $35.6 Billion by 2030, confirms Strategic Market Research.